Noritsu Koki Co., Ltd. Stock price

Equities

7744

JP3759500006

Recreational Products

Delayed Japan Exchange 01:00:00 2024-02-28 am EST 5-day change 1st Jan Change
3,190 JPY +1.11% Intraday chart for Noritsu Koki Co., Ltd. +5.28% +6.40%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2023 91.55B 608M Sales 2024 * 102B 677M Capitalization 113B 747M
Net income 2023 10.2B 67.69M Net income 2024 * 11.54B 76.57M EV / Sales 2023 1.17 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 1.1 x
P/E ratio 2023
10.5 x
P/E ratio 2024 *
9.84 x
Employees 1,184
Yield 2023
3.84%
Yield 2024 *
3.68%
Free-Float 50.34%
More Fundamentals * Assessed data
Dynamic Chart
Noritsu Koki Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
OMRON Corporation completed the acquisition of a 33% stake in JMDC Inc. from Noritsu Koki Co., Ltd.. CI
Omron and JMDC Sign $973 Million Capital and Business Alliance Deal MT
OMRON Corporation entered into a share transfer agreement to acquire 33% stake in JMDC Inc. from Noritsu Koki Co., Ltd. for ¥110 billion. CI
Noritsu Koki Co., Ltd. completed the acquisition of JLab Audio, Inc. from Eagle Fund II, L.P. of Eagle Private Capital, LLC, Petra Growth Fund II, L.P. of Petra Capital Partners, LLC, PEAG Advisors, LLC and others. CI
Noritsu Koki Co., Ltd. agreed to acquire JLab Audio, Inc. from Eagle Fund II, L.P. of Eagle Private Capital, LLC, Petra Growth Fund II, L.P. of Petra Capital Partners, LLC and others for ¥35 billion. CI
Hikari Tsushin, Inc. completed the acquisition of NIHONKYOSAI Co., Ltd. from Noritsu Koki Co., Ltd.. CI
AP67 Co., Ltd completed the acquisition of DENTAL Holding Corp. from Noritsu Koki Co., Ltd.. CI
Eurofins Clinical Testing Holding LUX SARL completed the acquisition of GeneTech Inc. from Noritsu Koki Co., Ltd.. CI
Eurofins Scientific : French group Eurofins signs deal to buy Japanese company GeneTech RE
Eurofins Clinical Testing Holding LUX SARL entered into an agreement to acquire GeneTech Inc. from Noritsu Koki Co., Ltd.. CI
AP67 Co., Ltd entered into an agreement to acquire DENTAL Holding Corp. from Noritsu Koki Co., Ltd.. CI
HLMK2 Co., Ltd acquired 94.92% stake in HALMEK Holdings Co., Ltd from Noritsu Koki Co., Ltd.. CI
Hikari Tsushin, Inc. agreed to acquire NIHONKYOSAI Co., Ltd. from Noritsu Koki Co., Ltd.. CI
An unknown buyer agreed to acquire 10% stake in JMDC Inc. from Noritsu Koki Co., Ltd. for ¥15.9 billion. CI
More news
1 day+1.11%
1 week+5.28%
Current month-4.78%
1 month-4.06%
3 months+5.11%
6 months+12.48%
Current year+6.40%
More quotes
1 week
3 060.00
Extreme 3060
3 200.00
1 month
2 860.00
Extreme 2860
3 370.00
Current year
2 860.00
Extreme 2860
3 450.00
1 year
2 097.00
Extreme 2097
3 450.00
3 years
1 725.00
Extreme 1725
3 450.00
5 years
748.00
Extreme 748
3 450.00
10 years
370.00
Extreme 370
3 450.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 45 18-05-31
Director of Finance/CFO 41 13-04-30
Chief Administrative Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 45 18-05-31
Director/Board Member 51 15-06-28
Director/Board Member 70 03-05-31
More insiders
Date Price Change Volume
24-02-28 3,190 +1.11% 90 000
24-02-27 3,155 +0.48% 109,900
24-02-26 3,140 +1.29% 74,400
24-02-22 3,100 +2.31% 151,000
24-02-21 3,030 -0.33% 75,700

Delayed Quote Japan Exchange, February 28, 2024 at 01:00 am EST

More quotes
Noritsu Koki Co., Ltd. is a company principally engaged in the manufacturing business, healthcare business and other businesses. The Company operates in six business segments. The Manufacturing segment is engaged in the research, development and manufacture of pen nib parts and cosmetics materials, among others. The Healthcare segment is engaged in the research, development and sale of radiological business support services by remote diagnostic imaging in the healthcare area, the analysis of received data and the provision of survey data, among others. The Drug Discovery segment develops new products in biotechnology area. The Senior and Life segment conducts senior publishing and mail order sales business. The Agri-food segment conducts the production and sale of fresh vegetables in the agri-food field. The Others segment conducts new growth related survey and investment business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3,155 JPY
Average target price
4,800 JPY
Spread / Average Target
+52.14%
Consensus
  1. Stock
  2. Equities
  3. Stock Noritsu Koki Co., Ltd. - Japan Exchange
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW